Submission date
17/01/2006
Registration date
02/03/2006
Last edited
24/06/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Retrospectively registered
? Protocol not yet added
? SAP not yet added
Results added
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Prof Norbert Donner-Banzhoff

ORCID ID

Contact details

University of Marburg
Department of General Practice and Family Medicine
Robert-Koch-Strasse 5
Marburg
35033
Germany
+49 (0)64 2128 65119
norbert@med.uni-marburg.de

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Randomized phase III trial: a decision aid in cardiovascular prevention - risk consultation related to absolute and relative risk

Acronym

ARRIBA

Study hypothesis

A consultation based on ARRIBA leads to:
1. An improved quality of counselling (patient's perceived assessment scale)
2. Changes in prescribing behaviour based on risk status

Ethics approval(s)

Ethical Committee of the University of Marburg, 18/10/2004, ref: 134/04

Study design

Two-arm parallel controlled cluster randomized intervention study

Primary study design

Interventional

Secondary study design

Cluster randomised trial

Study setting(s)

Not specified

Study type

Quality of life

Patient information sheet

Condition

Cardiovascular disease

Intervention

1. Intervention:
a. Advanced training (continuing education) in shared decision-making, risk calculation, risk communication and the use of decision aids
b. Advanced training in ARRIBA (decision aid and consultation)
2. Control:
Controls receive training after termination of the study

Intervention type

Other

Primary outcome measure

Patient's attitude towards consultation (patient's perceived assessment scale)

Secondary outcome measures

1. GPs: changes in prescribing behaviour and consultation related to risk status
2. Patients: cardiovascular risk status after six months

Overall study start date

01/11/2004

Overall study end date

31/10/2006

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

1. Age >18 years
2. Written informed consent
3. Measurement of cholesterol

Participant type(s)

Patient

Age group

Adult

Lower age limit

18 Years

Sex

Both

Target number of participants

1100

Participant exclusion criteria

Insufficient mental or verbal ability

Recruitment start date

01/11/2004

Recruitment end date

31/10/2006

Locations

Countries of recruitment

Germany

Study participating centre

University of Marburg
Marburg
35033
Germany

Sponsor information

Organisation

University of Marburg, Department of General Practice and Family Medicine (Germany)

Sponsor details

Robert-Koch-Strasse 5
Marburg
35033
Germany
+49 (0)64 2128 65120
baum@med.uni-marburg.de

Sponsor type

University/education

Website

ROR

https://ror.org/01rdrb571

Funders

Funder type

Government

Funder name

Bundesministerium für Bildung und Forschung

Alternative name(s)

Federal Ministry of Education and Research, BMBF

Funding Body Type

government organisation

Funding Body Subtype

National government

Location

Germany

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/06/2012 Yes No
Results article results 02/07/2013 Yes No

Additional files

Editorial Notes